Advertencia por liquidación de EPS: riesgos para atención, finanzas del sistema y continuidad de tratamientos

TL;DR

Abrupt liquidation of intervened EPS entities could lead to significant risks for patients, hospitals, and system operations.
Without a proven transition plan, the state may be unable to manage the immediate care, financial, and operational consequences.
EPS play crucial roles in managing health risks, organizing care networks, and ensuring continuity of treatment.
Liquidating EPS without a proven operational substitute would create an immediate functional void, as no public entity can currently manage millions of services simultaneously.
Patients, especially those with chronic or high-cost illnesses, face increased risks in receiving timely medication and vital procedures.
The financial system would experience a break in the payment chain, affecting millions of citizens and thousands of healthcare providers.
The healthcare system faces structural underfunding, non-compliance with court orders, regulatory deficiencies, and politicization.
Government debts to the health sector are increasing, exceeding $2 trillion by the end of 2025.
The UPC update for 2026 indicates additional underfunding, insufficient for current needs and benefit plan expansions.
The maximum budget for the current year is only 25% of what is needed for certain patient care costs.
Increases in the minimum wage, not factored into UPC calculations, will raise operational costs.
Responsible transformation requires legal approval, gradual transition, proven models, financial sufficiency, and clear responsibilities.

Continuar leyendo el artículo original